OTC: PBIGF - Paradigm Biopharmaceuticals Limited

Lønnsomhet i seks måneder: -26.05%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Paradigm Biopharmaceuticals Limited

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Paradigm Biopharmaceuticals Limited

Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.

Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета aud
Сайт https://www.paradigmbiopharma.com
Цена ао 0.1147
Prisendring per dag: 0% (0.1405)
Prisendring per uke: 0% (0.1405)
Prisendring per måned: 0% (0.1405)
Prisendring over 3 måneder: +5.4% (0.1333)
Prisendring over seks måneder: -26.05% (0.19)
Prisendring per år: -48.69% (0.2738)
Prisendring over 3 år: -90.24% (1.44)
Prisendring over 5 år: -85.81% (0.99)
Prisendring over 10 år: 0% (0.1405)
Prisendring siden begynnelsen av året: 0% (0.1405)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 1207.21 1
P/BV 3.34 5
P/E 0 0
EV/EBITDA -1.06 0
Total: 3.38

Effektivitet

Navn Betydning Karakter
ROA, % -91.65 0
ROE, % -112.45 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0041 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % -97.79 0
Lønnsomhet Ebitda, % 385.35 10
Lønnsomhet EPS, % 209.58 10
Total: 8
Flere detaljer

Institusjoner Volum Dele, %
Vanguard International Stock Index-Total Intl Stock Indx 3456896 0.99
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 2117667 0.6
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index 1055062 0.3
Vanguard International Stock Index-Pacific Stock Index 392059 0.11
SPDR Portfolio Developed World ex-US ETF 169911 0.05
SPDR (R) Idx Shares-SPDR (R) S&P (R) International Small Cap ETF 105574 0.03
Vanguard Intl Equity Index - Total World Stock Index Fd 71921 0.02
DFA Asia Pacific Small Company Series 59638 0.02
Vanguard World Fund-Vanguard ESG International Stock ETF 43440 0.01



Veileder Stillingstittel Betaling Fødselsår
Mr. Paul John Rennie BSc, Grad Dip, MBM, MSTC Founder, MD & Executive Chairman 1.17M 1959 (66 år)
Dr. Donna L. Skerrett M.D., MS Chief Medical Officer and Executive Director 843.69k 1957 (68 år)
Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A. Company Secretary & CFO N/A
Dr. Ravi Krishnan Chief Scientific Officer N/A
Mr. Simon White Director of Investor Relations N/A
Dr. Michael Imperiale Global Head of Drug Safety & MPS N/A
Ms. Beverley Huttmann Commercial Head N/A
Ms. Michelle Coffey Global Head of Regulatory Affairs N/A
Dr. Mukesh Ahuja Global Clinical Head of OA N/A

Adresse: Australia, Melbourne, 500 Collins Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.paradigmbiopharma.com